Abstract: An enhanced map information processing unit 14 of a driving assistance device 1 acquires from a determination unit 13 information on surroundings of a vehicle which is needed to perform autonomous driving, and acquires from a server device 2 environment information on surroundings of a route on which autonomous driving is performed. On the basis of the acquired environment information, the enhanced map information processing unit 14 extracts, as an autonomous driving unsuitable location Pn, a location at which the accuracy of the acquirement of the sensor unit 12 is predicted not to satisfy a standard for acquiring the information on the surroundings of the vehicle needed to perform autonomous driving. An informing unit 18 alerts the extracted autonomous driving unsuitable location Pn to a user.

Abstract: The disclosure provides pyrazolo[1,5-a]pyrimidine compounds, and pharmaceutically acceptable salts thereof, having protease-activated receptor 2 (PAR2) inhibitory action, pharmaceutical compositions containing the same, and methods of treatment using the same.

Abstract: The compounds represented by formulas (I) to (XVIII) or pharmaceutically acceptable salts thereof.

Abstract: An enhanced map information processing unit 14 of a driving assistance device 1 acquires from a determination unit 13 information on surroundings of a vehicle which is needed to perform autonomous driving, and acquires from a server device 2 environment information on surroundings of a route on which autonomous driving is performed. On the basis of the acquired environment information, the enhanced map information processing unit 14 extracts, as an autonomous driving unsuitable location Pn, a location at which the accuracy of the acquirement of the sensor unit 12 is predicted not to satisfy a standard for acquiring the information on the surroundings of the vehicle needed to perform autonomous driving. An informing unit 18 alerts the extracted autonomous driving unsuitable location Pn to a user.

Abstract: A display device for a vehicle includes a decorative member; a light source that emits light to the decorative member; and a virtual image generation unit that displays a virtual image between a driver of the vehicle and the decorative member. The light source is disposed closer to the driver than the decorative member, and is alternately switchable between a light-on state and a light-off state when the virtual image generation unit displays a virtual image.

Abstract: An enhanced map information processing unit 14 of a driving assistance device 1 acquires from a determination unit 13 information on surroundings of a vehicle which is needed to perform autonomous driving, and acquires from a server device 2 environment information on surroundings of a route on which autonomous driving is performed. On the basis of the acquired environment information, the enhanced map information processing unit 14 extracts, as an autonomous driving unsuitable location Pn, a location at which the accuracy of the acquirement of the sensor unit 12 is predicted not to satisfy a standard for acquiring the information on the surroundings of the vehicle needed to perform autonomous driving. An informing unit 18 alerts the extracted autonomous driving unsuitable location Pn to a user.

Abstract: A vehicle display apparatus includes a left decorative panel and a right decorative panel each including a first instrument panel and a second instrument panel, a left rotating mechanism that rotates the left decorative panel about an axis of rotation and changes which of the first instrument panel and the second instrument panel to be allowed to face toward a driver in a vehicle, and a right rotating mechanism that rotates the right decorative panel about an axis of rotation and changes which of the first instrument panel and the second instrument panel to be allowed to face toward the driver in the vehicle.

Abstract: A display device for a vehicle includes a decorative member; a light source that emits light to the decorative member; and a virtual image generation unit that displays a virtual image between a driver of the vehicle and the decorative member. The light source is disposed closer to the driver than the decorative member, and is alternately switchable between a light-on state and a light-off state when the virtual image generation unit displays a virtual image.

Abstract: A novel chemical compound useful as a therapeutic or prophylactic agent for acid-related diseases is provided, which has an excellent inhibitory effect against gastric acid secretion, an excellent effect of maintaining the inhibitory effect against gastric acid secretion, thereby maintaining intragastric pH high for a long time, and having more safety and appropriate physicochemical stability. Provided is a compound represented by where R1 and R3 may be the same or different and each represent a hydrogen atom or a C1-C6 alkyl group; R2 represents (5,5-dimethyl-1,3-dioxan-2-yl)methoxy group, 5,7-dioxaspiro[2.5]oct-6-ylmethoxy group, 1,5,9-trioxaspiro[5.5]undec-3-ylmethoxy group, or (2,2-dimethyl-1,3-dioxan-5-yl)methoxy group; R4, R5, R6 and R7 represent a hydrogen atom, halogen atom, C1-C6 alkyl group, C1-C6 haloalkyl group, C1-C6 alkoxy group or C1-C6 haloalkoxy group; and W1 represents a single bond, methylene or ethylene group, a salt thereof or a solvate of these.

Abstract: An information delivery system in which in a display device (2) for displaying a first content and a second content, a user's operation to the display device is analyzed when the user views the first content and when the operation is performed to change the first content, the second content is delivered from an information delivery device (1) that receives a delivery request to the display device and displayed. Therefore, the desired second content is provided without interrupting a user's viewing and hearing of the first content.

Abstract: An information delivery system in which in a display device (2) for displaying a first content and a second content, it is detected whether or not the displayed first content is changed to other content that is different from the first content and when the change is the predetermined change that is set in advance, the second content is delivered from an information delivery device (1) that receives a delivery request to the display device and displayed. Therefore, the desired second content is provided without interrupting a user's viewing of the first content.

Abstract: A cyclic amidine derivative represented by the formula: [wherein R1, R2 and R3 represent hydrogen, C1-6 alkyl, aryl-C1-6 alkyl, etc.; R4, R5 and R7 represent hydrogen, C1-6 alkyl, etc.; Z represents 0 or 1; R6 represents hydrogen, C1-6 alkyl, C1-6 alkyloxycarbonyl, etc.; n represents 1 or 2; Y1 represents a single bond, —CH2—, etc.; Y2 represents a single bond, —CO—, etc.; Ar represents hydrogen, a group represented by the formula: [wherein R10-R14 represent hydrogen, C1-6 alkyl, hydroxyl, C1-6 alkoxy, etc., and R11 and R12 or R12 and R13 may bond together to form a 5- to 8-membered heterocycle], etc.] or a salt thereof.

Abstract: A novel chemical compound useful as a therapeutic or prophylactic agent for acid-related diseases is provided, which has an excellent inhibitory effect against gastric acid secretion, an excellent effect of maintaining the inhibitory effect against gastric acid secretion, thereby maintaining intragastric pH high for a long time, and having more safety and appropriate physicochemical stability. Provided is a compound represented by where R1 and R3 may be the same or different and each represent a hydrogen atom or a C1-C6 alkyl group; R2 represents (5,5-dimethyl-1,3-dioxan-2-yl)methoxy group, 5,7-dioxaspiro[2.5]oct-6-ylmethoxy group, 1,5,9-trioxaspiro[5.5]undec-3-ylmethoxy group, or (2,2-dimethyl-1,3-dioxan-5-yl)methoxy group; R4, R5, R6 and R7 represent a hydrogen atom, halogen atom, C1-C6 alkyl group, C1-C6 haloalkyl group, C1-C6 alkoxy group or C1-C6 haloalkoxy group; and W1 represents a single bond, methylene or ethylene group, a salt thereof or a solvate of these.

Abstract: A storing-reproducing unit 200 recognizes a free space of a contents storage area by a storage-area-administrating device, sets a recording timing duration based on the recognized free space of the contents storage area, and selects a schedule information of a contents to be recorded from recording schedule list information. Hence, frequency of storing the contents in the HDD 270 can be reduced, thereby avoiding that the contents which has not yet watched is erased by self-erasing, so that the contents can be effectively recorded. Therefore, a user can secure flexibility in time in watching the contents.

Abstract: Salts of 2-[({4-[(2,2-dimethyl-1,3-dioxan-5-yl)methoxy]-3,5-dimethylpyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole and their crystalline and amorphous forms.

Abstract: A compound represented by the following general formula (1) or (100), a salt thereof or a hydrate of the foregoing has excellent cell adhesion inhibitory action and cell infiltration inhibitory action. wherein R10 represents 5- to 10-membered cycloalkyl etc. optionally substituted with hydroxyl etc., R30, R31 and R32 may be the same or different and each represents hydrogen etc., R40 represents C1-10 alkyl etc. optionally substituted with hydroxyl etc., n represents an integer of 0, 1 or 2, X1 represents CH or nitrogen, and R20, R21, R22 and R23 may be the same or different and each represents hydrogen etc.

Abstract: In one aspect, the present invention provides compounds having formula (1) or (100), a salt thereof or a hydrate of the foregoing, which compounds exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action, and are useful as therapeutic or prophylactic agents for various inflammatory diseases and autoimmune diseases associated with adhesion and infiltration of leukocytes, such as inflammatory bowel disease (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome; rheumatoid arthritis, psoriasis, multiple sclerosis, asthma and atopic dermatitis. wherein R10 represents optionally substituted cycloalkyl, etc., R20-23 represent hydrogen, alkyl, alkoxy, etc., R30-32 represent hydrogen, alkyl, oxo, etc., and R40 represents optionally substituted alkyl, etc.

Abstract: An object of the present invention is to provide a novel chemical compound useful as a therapeutic or prophylactic agent for acid-related diseases, having an excellent inhibitory effect against gastric acid secretion, an excellent effect of maintaining the inhibitory effect against gastric acid secretion, thereby maintaining intragastric pH high for a long time, and having more safety and appropriate physicochemical stability. Provided is a compound represented by where R1 and R3 may be the same or different and each represent a hydrogen atom or a C1-C6 alkyl group; R2 represents (5,5-dimethyl-1,3-dioxan-2-yl)methoxy group, 5,7-dioxaspiro[2.5]oct-6-ylmethoxy group, 1,5,9-trioxaspiro[5.5]undec-3-ylmethoxy group, or (2,2-dimethyl-1,3-dioxan-5-yl)methoxy group; R4, R5, R6 and R7 represent a hydrogen atom, halogen atom, C1-C6 alkyl group, C1-C6 haloalkyl group, C1-C6 alkoxy group or C1-C6 haloalkoxy group; and W1 represents a single bond, methylene or ethylene group, a salt thereof or a solvate of these.